By The Stroke Association (2017)
This report estimates that the current cost of stroke to the UK is £26 billion every year, a threefold increase from the previous estimated cost of £9 billion. The figures also predict that a growing and ageing population, increasing numbers of stroke survivors, and rising care costs are crucial factors behind the increasing financial burden of stroke over the next 20 years.
Click here to view this report
Panella, M. et al. BMC Medicine, 2012: 10:71
Clinical pathways (CPs) are used to improve the outcomes of acute stroke, but their use in stroke care is questionable, because the evidence on their effectiveness is still inconclusive. The objective of this study was to evaluate whether CPs improve the outcomes and the quality of care provided to patients after acute ischemic stroke.
Click here to view this full text article
Carey, KM. et al. Annals of Pharmacology, 2012; 46(5): 688-695
This article aims to evaluate the efficacy and safety of the polypill for prevention of cardiovascular disease (CVD) and stroke and to present literature related to the polypill components (statin, aspirin, antihypertensive) for primary prevention of CVD and stroke.
Please contact your local NHS Health Library (NHS staff only) to request this article
By NHS Improvement (2012)
An information resource for providers and commissioners of stroke rehabilitation and early supported discharge services in the community.
Click here to view this resource